Reviewing NeurAxis (NASDAQ:NRXS) and Cutera (NASDAQ:CUTR)

Cutera (NASDAQ:CUTR) and NeurAxis (NASDAQ:NRXS) are both small-cap computer and technology companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, risk, profitability, valuation and earnings.

Analyst Ratings

This is a summary of recent recommendations and price targets for Cutera and NeurAxis, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cutera	0	2	2	0	2.50
NeurAxis	0	0	1	0	3.00

Cutera presently has a consensus target price of $7.67, suggesting a potential upside of 411.11%. Given Cutera’s higher probable upside, equities analysts clearly believe Cutera is more favorable than NeurAxis.

Institutional and Insider Ownership

90.7% of Cutera shares are held by institutional investors. Comparatively, 11.8% of NeurAxis shares are held by institutional investors. 0.4% of Cutera shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Profitability

This table compares Cutera and NeurAxis’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Cutera	-73.42%	N/A	-37.78%
NeurAxis	-633.10%	N/A	-926.02%

Earnings and Valuation

This table compares Cutera and NeurAxis’ revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cutera	$212.37 million	0.14	-$162.83 million	($7.22)	-0.21
NeurAxis	$2.46 million	7.62	-$14.63 million	($3.73)	-0.76

NeurAxis has lower revenue, but higher earnings than Cutera. NeurAxis is trading at a lower price-to-earnings ratio than Cutera, indicating that it is currently the more affordable of the two stocks.

Summary

Cutera beats NeurAxis on 8 of the 12 factors compared between the two stocks.

About Cutera

Cutera, Inc. provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for deep dermal remodeling; truFlex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; and excel V+, a vascular and benign pigmented lesion treatment platform. It also offers truSculpt, a high-powered radio frequency system designed for circumferential reduction, lipolysis, and deep tissue heating and treat all body and skin types; Secret RF, a fractional RF microneedling device that delivers heat into the deeper layers of the skin using controlled RF energy; and enlighten, a laser platform with a dual wavelength for multi-colored tattoo removal, and the treatment of benign pigmented lesions and acne scars. In addition, the company provides excel HR, a hair removal solution for all skin types; and xeo, a multi-application platform for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity. Further, it offers its products through direct sales and services, and network of distributors and direct international sales. Cutera, Inc. was incorporated in 1998 and is headquartered in Brisbane, California.

About NeurAxis

NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome. The company sells its products to healthcare companies, including hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.